Questcor Pharmaceuticals Inc Files (8-K) Disclosing Other Events
ITEM 8.01 OTHER EVENTS Settlement of Certain Litigation As previously disclosed at page 170 of the definitive joint proxy statement/prospectus dated under the heading "Litigation Relating to the Transaction," certain actions were filed by putative shareholders of shareholders because, among other things, the proposed merger in which Mallinckrodt ... (more)
Sat Jul 26, 2014
Questcor Pharmaceuticals Stock Rating Lowered by Oppenheimer
They currently have a $86.00 target price on the stock. Oppenheimer's target price would suggest a potential downside of 9.38% from the stock's previous close.
Fri Jul 25, 2014
Hedge fund Greenlight details short bets, still likes Apple
Hedge fund manager David Einhorn's Greenlight Capital told investors on Friday that it has short bets against supermarket chain Safeway Inc. and Questcor Pharmaceuticals which was is being taken over by Mallinckrodt Pharmaceuticals.
Thu Jul 24, 2014
Questcor Pharmaceuticals (QCOR) Posts Quarterly Earnings, Beats Expectations By $0.11 EPS
Questcor Pharmaceuticals announced its earnings results on Thursday. The company reported $1.85 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.74 by $0.11, StockRatingsNetwork.com reports.
Questcor Pharmaceuticals, Inc. (Headquarters) Reports Record Second Quarter Financial Results
Net sales for H.P. ActharA Gel for the second quarter ended in non-GAAP net sales in the second quarter of June 2013.
MS drug sales drive Questcor profit
Questcor Pharmaceuticals Inc posted a 39.5 percent rise in quarterly profit, helped by strong sales of multiple sclerosis drug Acthar.
Wed Jul 16, 2014
Questcor Pharmaceuticals Insider Don M. Bailey Sells 40,000 Shares
Questcor Pharmaceuticals Insider Don M. Bailey unloaded 40,000 shares of Questcor Pharmaceuticals stock in a transaction dated Monday, July 14th.
Tue Jul 15, 2014
Dumb Investment Of The Week: Mallinckrodt Plc
On April 7, 2014, Mallinckrodt Plc , a specialty pharmaceutical company, announced it entered into an agreement to purchase Questcor Pharmaceuticals for approximately $5.6B .
Mon Jul 14, 2014
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals, Inc....
The registration statement on Form S-4 is available on the SEC's EDGAR system, and may be accessed at: http://www.sec.gov .
Fri Jul 11, 2014
Questcor Pharmaceuticals, Inc. (Headquarters) Finally Fesses Up To Adverse Events Data For Acthar
But according to a regulatory filing made by Questcor early Thursday, the number of patients reporting a so-called adverse event while using the drug last year represented almost 5 percent of prescriptions dispensed.
Thu Jul 10, 2014
Questcor's Acthar Gel: Clinical Usage Suggests Efficacy
Questcor Pharmaceuticals has a medication known as Acthar Gel, which has been manufactured since the 1950s.
Thu Jul 03, 2014
Questcor Pharmaceuticals Reaches New 1-Year High at $94.87
Shares of Questcor Pharmaceuticals hit a new 52-week high during mid-day trading on Thursday , StockRatingsNetwork reports.